Serum and tissue expression of gelatinase and Twist in breast cancer

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 18, 2014, Pages 2662-2669

  Huang, J ^a   Ang, L ^a   Liu, M Q ^a   Hu, H G ^a   Wang, J ^a   Zou, Q ^a   Zhao, Y ^a   Zheng, L ^a   Zhao, M ^a   Wu, Z S ^b  

^a The Second People's Hospital of Hefei   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasm; ELISA; Gelatinases; Immunohisto chemistry; Twist

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; GELATINASE B; TRANSCRIPTION FACTOR TWIST; TUMOR MARKER; GELATINASE; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; NUCLEAR PROTEIN; TWIST1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE LEVEL; VERY ELDERLY; BIOSYNTHESIS; BLOOD; BREAST NEOPLASMS; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL; TWIST TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84938376191     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ECCLES SA, WELCH DR. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007;369:1742-1757.
2. WU ZS, WU Q, YANG JH, WANG HQ, DING XD, YANG F, XU XC. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 2008;122:2050-2056.
3. SHAH FD, SHUKLA SN, SHAH PM, SHUKLA HK, PATEL PS. Clinical significance of matrix metallopro-teinase 2 and 9 in breast cancer. Indian J Cancer 2009;46:194-202.
4. DANIELE A, ZITO A F, GIANNELLI G, DIVELLA R, ASSELTI M, MAZZOCCA A, PARADISO A, QUARANTA M. Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. An-ticancer Res 2010;30:3521-3527.
5. ONDER TT, GUPTA PB, MANI SA, YANG J, LANDER ES, WEINBERG RA. Loss of E-cadherin promotes metastasis via multiple downstream transcription-al pathways. Cancer Res 2008;68:3645-3654.
6. MANI SA, GUO W, LIAO MJ, EATON EN, AYYANAN A, ZHOU AY, BROOKS M, REINHARD F, ZHANG CC, SHIPITSIN M, CAMPBELL LL, POLYAK K, BRISKEN C, YANG J, WEINBERG RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715.
7. ZHAO M, HU HG, HUANG J, ZOU Q, WANG J, LIU MQ, ZHAO Y, LI GZ, XUE S, WU ZS. Expression and correlation of Twist and gelatinases in breast cancer. Exp Ther Med 2013;6:97-100.
8. TUTTON MG, GEORGE ML, ECCLES SA, BURTON S, SWIFT RI, ABULAFI AM. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in col-orectal cancer patients. Int J Cancer 2003;107:541-550.
9. GIANNELLI G, BERGAMINI C, MARINOSCI F, FRANSVEA E, QUARANTA M, LUPO L, SCHIRALDI O, ANTONACI S. Clinical role of MMP-2/TIMP-2 imbalance in hepato-cellular carcinoma. Int J Cancer 2002;97:425-431.
10. GUAN K P, YE HY, YAN Z, WANG Y, HOU SK. Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder. Urology 2003;61:719-723.
11. ZUCKER S, LYSIK RM, DI MASSIMO BI, ZARRABI HM, MOLL UM, GRIMSON R, TICKLE S P, DOCHERTY AJ. Plasma assay of gelatinase B: tissue inhibitor of metallopro-teinase complexes in cancer. Cancer 1995;76:700-708.
12. TAVASSOLI FA, DEVILEE P. World health organization classification of tumors: pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press, 2003; pp. 13-59.
13. KYO S, SAKAGUCHI J, OHNO S, MIZUMOTO Y, MAIDA Y, HASHIMOTO M, NAKAMURA M, TAKAKURA M, NAKAJIMA M, MASUTOMI K, INOUE M. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006;37:431-438.
14. SHIMIZU M, SAITOH Y, ITOH H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol 1990;21:607-612.
15. LEPPÄ S, SAARTO T, VEHMANEN L, BLOMQVIST C, ELOMAA I. A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res 2004;10:1057-1063.
16. DRAGUTINOVIC V, IZRAEL-ZIVKOVIC L, RADOVANOVIC N. Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer. Dig Dis Sci 2009;54:1203-1207.
17. KLEINER DE, STETLER-STEVENSON WG. Matrix metallo-proteinases and metastasis. Cancer Chemother Pharmacol 1999;43 Suppl: S42-S51.
18. BOURBOULIA D, STETLER-STEVENSON WG. Matrix metal-loproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 2010;20:161-168.
19. STETLER-STEVENSON WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990;9:289-303.
20. LIOTTA LA, STEEG PS, STETLER-STEVENSON WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-336.
21. KYO S, SAKAGUCHI J, OHNO S, MIZUMOTO Y, MAIDA Y, HASHIMOTO M, NAKAMURA M, TAKAKURA M, NAKAJIMA M, MASUTOMI K, INOUE M. High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006;37:431-438.
22. MAESTRO R, DEI TOS A P, HAMAMORI Y, KRASNOKUTSKY S, SARTORELLI V, KEDES L, DOGLIONI C, BEACH DH, HANNON GJ. Twist is a potential oncogene that inhibits apoptosis. Genes Dev 1999;13:2207-2217.
23. BATES RC, MERCURIO AM. The epithelial-mesenchy-mal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 2005;4:365-370.
24. XUE C, PLIETH D, VENKOV C, XU C, NEILSON EG. The gatekeeper effect of epithelial-mesenchy-mal transition regulates the frequency of breast cancer metastasis. Cancer Res 2003;63:3386-3394.
25. MATSUO N, SHIRAHA H, FUJIKAWA T, TAKAOKA N, UEDA N, TANAKA S, NISHINA S, NAKANISHI Y, UEMURA M, TAKAKI A, NAKAMURA S, KOBAYASHI Y, NOUSO K, YAGI T, YAMAMOTO K. Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 2009;9:240.
26. SMIT MA, GEIGER TR, SONG J Y, GITELMAN I, PEEPER DS. A Twist-Snail axis critical for TrkB-induced epithe-lial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 2009;29:3722-3737.
27. YANG MH, CHEN CL, CHAU GY, CHIOU SH, SU CW, CHOU TY, PENG WL, WU JC. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009;50:1464-1474.
28. FOUBERT E, DE CRAENE B, BERX G. Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression. Breast Cancer Res 2010;12:206.
29. YANG J, MANI SA, DONAHER JL, RAMASWAMY S, ITZYKSON RA, COME C, SAVAGNER P, GITELMAN I, RICHARDSON A, WEINBERG RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-939.
30. RASHAD YA, ELKHODARY TR, EL-GAYAR AM, EISSA LA. Evaluation of serum levels of HER2, MMP-9, nitric oxide, and total antioxidant capacity in egyptian breast cancer patients: correlation with clinico-pathological parameters. Sci Pharm 2013;82:129-145.
31. RUOKOLAINEN H, PÄÄKKÖ P, TURPEENNIEMI-HUJANEN T. Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma-tissue immunoreactivity predicts aggressive clinical course. Mod Pathol 2006;19:208-217.
32. RUOKOLAINEN H, PÄÄKKÖ P, TURPEENNIEMI-HUJANEN T. Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker. Int J Cancer 2005;116:422-427.